Ropes & Gray Named “Law Firm of the Year—Pharmaceutical & Biotechnology” at The Deal Awards

Practices: Mergers & Acquisitions, Life Sciences Licensing, Collaborations & Joint Ventures, Digital Health, Capital Markets, Securities & Public Companies, Intellectual Property Transactions, IP Structuring in M&A, Spinouts & Reorganizations, Strategic Licensing Programs, Joint Ventures, Collaborations and Alliances, Strategic Commercial Agreements, Venture Capital & Emerging Companies , FDA Regulatory, Drug Pricing & Price Reporting Industries: Healthcare & Life Sciences

The Deal named Ropes & Gray “Law Firm of the Year—Pharmaceutical & Biotechnology” at its annual awards New York City on September 29.

Our life sciences team, in 2021 and 2022, guided several of the industry’s most significant deals by deal size and complexity. The firm also represented clients in two of the top five biopharmaceutical mergers & acquisitions and three of the top-ten biopharmaceutical licensing and collaboration deals in 2021 measured by deal value, according to an analysis of data published in PharmaCompass.

With one of the leading life sciences and health care industry practices in the world, Ropes & Gray has the knowledge and experience to help global clients succeed.

The firm’s global practice represents life sciences and health care clients in every stage of their growth and development, across transactions, regulatory, compliance, litigation, antitrust and enforcement.

Cookie Settings